Harveer Dev
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Diagnosis and Treatment 6
- Prostate Cancer Treatment and Research 6
- Oncology 5
- PARP inhibition in cancer therapy 3
- Co-authors
- Prasanna Sooriakumaran (8 shared papers)Samih Al‐Hayek (6 shared papers)Nathan Lawrentschuk (6 shared papers)Sani Hussein Aliyu (5 shared papers)Nathan P. Papa (5 shared papers)David E. Neal (4 shared papers)Ashutosh Kumar Tewari (3 shared papers)Douglas W. Skarecky (2 shared papers)
- Journals
- World Journal of Urology (3 papers)British Journal of Urology (3 papers)The Journal of Urology (1 paper)QJM (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Harveer Dev
25 papers receiving 944 citations
Peers
Comparison fields: 5 of 82
- Oncology 360
- Pulmonary and Respiratory Medicine 353
- Molecular Biology 421
- Cancer Research 73
- Molecular Medicine 26
Countries citing papers authored by Harveer Dev
This map shows the geographic impact of Harveer Dev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harveer Dev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harveer Dev more than expected).
Fields of papers citing papers by Harveer Dev
This network shows the impact of papers produced by Harveer Dev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harveer Dev. The network helps show where Harveer Dev may publish in the future.
Co-authors
The 25 scholars most cited alongside Harveer Dev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 324 | |
| 2 | 2017 | 227 | |
| 3 | 2014 | 73 | |
| 4 | 2015 | 46 | |
| 5 | 2016 | 35 | |
| 6 | 2008 | 33 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 29 | |
| 9 | 2011 | 27 | |
| 10 | 2021 | 27 | |
| 11 | 2012 | 19 | |
| 12 | 2011 | 19 | |
| 13 | 2011 | 14 | |
| 14 | 2011 | 13 | |
| 15 | 2015 | 13 | |
| 16 | 2010 | 9 | |
| 17 | 2024 | 9 | |
| 18 | 2024 | 7 | |
| 19 | 2018 | 2 | |
| 20 | 2017 | 2 |
About Harveer Dev
Harveer Dev is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Medicine, Infectious Diseases and Surgery, having authored 26 papers that have together received 965 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers), PARP inhibition in cancer therapy (3 papers), Surgical Simulation and Training (3 papers), Cancer Genomics and Diagnostics (2 papers), Innovations in Medical Education (2 papers), Urinary Tract Infections Management (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Oncology (360 citations), Pulmonary and Respiratory Medicine (353 citations), Molecular Biology (421 citations), Cancer Research (73 citations) and Molecular Medicine (26 citations). Harveer Dev has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Prasanna Sooriakumaran, Samih Al‐Hayek, Nathan Lawrentschuk, Sani Hussein Aliyu, Nathan P. Papa, David E. Neal, Ashutosh Kumar Tewari, Douglas W. Skarecky, Nimish C Shah and Thomas Edward Ahlering. Their work appears in journals such as World Journal of Urology, British Journal of Urology, The Journal of Urology, QJM and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.